STAT1 as a New Molecular Target of Anti-Inflammatory Treatment
Authors: de Prati, Alessandra C.; Ciampa, Anna R.; Cavalieri, Elisabetta; Zaffini, Raffaela; Darra, Elena; Menegazzi, Marta; Suzuki, Hisanori; Mariotto, Sofia
Source: Current Medicinal Chemistry, Volume 12, Number 16, August 2005 , pp. 1819-1828(10)
Publisher: Bentham Science Publishers
Abstract:Cyclooxygenase (COX) is widely considered as the molecular target of non-steroid anti-inflammatory drugs (NSAIDs). However, due to the harmful side effect frequently observed following chronic use, the development of new anti-inflammatory agents is the matter of many studies.
Signal transducers and activators of transcription (STAT) are a family of nuclear proteins mediating the action of a number of cytokines. Among them, STAT1 plays a critical role in the signal transduction pathway of interferon-gamma (IFN-gamma) and growth hormone. STAT1 cascade is one major signalling pathway converting the IFN-gamma signal into gene expression, such as inducible nitric oxide synthase (iNOS), COX, vascular cell adhesion molecules (VCAM) and intercellular cell adhesion molecules (ICAM), critically involved in different pathologies correlated to the inflammatory process.
This review focuses the attention on an alternative approach to the development of novel drugs based on inhibition of STAT1 pathway.
In this context, a growing interest has been focused on natural compounds. We have recently reported a several data indicating that green tea extract (GTE), St. John's Wort extract and epigallocatechin-3-gallate (EGCG) exhibit a specific and strong anti-STAT1 activity which is independent of their acclaimed strong anti-oxidant activity. More recently, GTE has been shown to protect heart damage from ischaemia/reperfusion in rats, suggesting that the protective effect of green tea might be correlated to its anti-STAT1 activity.
The present review is aimed at providing data that STAT1 may potentially be claimed as a new molecular target of an anti-inflammatory treatment and that among natural compounds there are a number of anti-STAT1 substances.
Document Type: Review Article
Affiliations: Section of Biochemistry, Department of Neuroscience and Vision, University of Verona, Strada Le Grazie, 8, 37134 Verona, Italy;
Publication date: August 2005
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.